← Human Trials & Peer-Reviewed Studies
The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis.
Plain-language guide to PMID 37103591 (2023): meta-analysis of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 37103591
- Journal
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
- Year
- 2023
- Study type
- Meta-Analysis
- Authors
- Moon RJ et al. (8 authors)
- DOI
- 10.1007/s00198-023-06751-5
What This Paper Covers, in Plain Language
What It Covers
Researchers studied Vitamin D, K2, Magnesium and Zinc in this meta-analysis publication.
A systematic review and meta-analysis was performed to assess the effect of pregnancy vitamin D supplementation on offspring bone mineral density (BMD) in childhood.
Who the Included Studies Covered
The age groups tagged for this paper are young children and children, women only.
A literature search was conducted for published RCTs of antenatal vitamin D supplementation with assessment of offspring BMD or bone mineral content (BMC) by dual-energy X-ray absorptiometry (DXA) using MEDLINE and EMBASE up to 13th July 2022.
Study findings were grouped in two age groups of offspring assessment: neonatal period and early childhood (3-6 years).
How the Review Was Done
Risk of bias was assessed using the Cochrane Risk of Bias 2 tool.
What Was Measured
PubMed files the paper under topics including Vitamin D, Bone Density, Vitamins, Cholecalciferol, Dietary Supplements and Randomized Controlled Trials as Topic.
Author keywords: BMD, Epidemiology, Osteoporosis, Pregnancy and RCT.
What This Means in Plain Language
This is a meta-analysis of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 9 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2023 (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.